Drug Approval | March 19, 2025
Briefs: Zydus, Alkem Laboratories, Alkem Medtech and Relonchem
Alkem Medtech to acquire 100% stake of Bombay Ortho
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The company has received Form 483 with three observations
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
The company has reported total income of Rs. 2971.27 crores during the period ended March 31, 2023
He holds a Bachelor’s Degree in Science and has joined the company in 2012 and has over 10 years of experience in pharmaceutical industry
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
Subscribe To Our Newsletter & Stay Updated
